Kevin McKernan, chief scientific officer of Medicinal Genomics, speaks on sequencing the cannabis genome and its implications for the cannabis industry and “personalized medicine”.
Kevin McKernan, chief scientific officer of Medicinal Genomics, speaks on sequencing the cannabis genome and its implications for the cannabis industry and “personalized medicine”.